Article Date: 28 Feb 2007 -
0:00 PST
Today, a leading neurology journal - European Journal of Neurology
(EJN) reports a study1 which shows that Sativex, a cannabis based
medicine, significantly reduces intractable spasms and stiffness (spasticity)
in people with Multiple Sclerosis (MS).
»
Read More
(( a
new patent-pending method to "reboot" a patient's immune system,))
Revimmune uses an approved drug in a new
patent-pending method to eliminate autoimmunity
In clinical studies for the lead indication of
multiple sclerosis (MS), Revimmune improves function in most
patients and stops progression in over 90% of cases refractory to
standard therapies.